Millennium Withdraws sNDA; Pfizer Stops Trial of Epilepsy Drug Lyrica - Oct. 6, 2011

Having trouble viewing this email? View in Browser.

Thursday, October 06, 2011  |   |   |   |  Ambion® Products...Superior Results Every Time Ambion® Products Represent Years of RNA Expertise. For over two decades, our scientists have developed high-quality, innovative RNA products that make your job easier with faster, more robust and more reliable results. Use the best and have confidence in your results...every time. Now, Ambion® products also include Invitrogen™ RNA products - all by Life Technologies. Please click here for more information. •  Millennium Withdraws sNDA for Velcade More... •  Perrigo Company (PRGO) Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam More... More BLA/NDA/ANDA News More IND News More MAA News •  Pfizer Inc. (PFE) Stops Trial of Epilepsy Drug Lyrica as Efficacy Proved More... •  Sanofi (France) (SASY.PA) and Genzyme Corporation (GENZ) Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio(TM)(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity More... •  Keryx Biopharmaceuticals (KERX) Release: Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Capecitabine in Patients with Metastatic Colorectal Cancer More... •  Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Combine Industry Leading Capabilities to Advance Unigene's Proprietary Peptides through Phase 2 Proof-of-Concept for the Treatment of Type 2 Diabetes, Osteoarthritis and Osteoporosis More... •  BioCancell Therapeutics to Commence Enrollment of Phase IIb Pancreatic Cancer Clinical Trial More... •  Peregrine Pharmaceuticals, Inc. (PPHM) Completes Patient Enrollment in Second-Line Non-Small Cell Lung Cancer Trial; Data to Be Unblinded in First Half 2012 More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Celgene (CELG) Asked to Specify Revlimid Cancer Risk More... More Discontinuations News More Recalls and Warning News Social & Scientific Systems, Inc., and panel members, Eleanor Feingold, Gina D'Angelo, and Joan Bailey-Wilson, invite you to join us at a symposium to honor Brad Efron for his many contributions to theoretical and applied statistics. We will be discussing emerging statistical challenges in large-scale inference, with a focus on applications in genetics and biomedical imaging. The goal of the symposium is to stimulate discussion; it will include both formal and informal meeting and discussion time, in addition to the featured speakers. The symposium is limited to 200 people. Please RSVP to: LargeData@s-3.com. Please click here for more information. •  Omega-3 Supplements Don't Help, May Hurt ICU Patients, McMaster University Study More... •  Everest Expedition Suggests Nitric Oxide Benefits for Intensive Care Patients, University of Warwick Study More... •  3 Hours of Exercise Weekly Can Cut Men's Heart Risks, Harvard School of Public Health Study More... •  Survival Increases in Early Stage Breast Cancer After Treatment With Herceptin and Chemo, University of California, Los Angeles (UCLA) Study More... •  Invasive Melanoma May be More Likely in Children Than Adults, Johns Hopkins University Study More... More General Clinical Research News Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. • Biotech Beach (San Diego, California) Sequenom Inc. Clinical Laboratory Supervisor Will be responsible for monitoring the production of medical diagnostic testing in the CLIA lab performed by assigned Clinical Lab Scientists. The supervisor will work closely with internal and external contacts including suppliers, physicians and other healthcare providers regarding clinical laboratory testing, operations and development of new tests. • Pharm Country (Radnor, Pennsylvania) PolyMedix, Inc. Clinical Trial Operations Manager/Director Experience in execution of Phase II Phase II pivotal studies, Phase III and small Phase I studies and larger, multi-center trial management. Experience in infectious diseases and/or cardio vascular. Well versed in GCP and applicable FDA/EMEA regulations required. Ability to prepare and present clinical trial updates to senior management. • Biotech Bay (San Jose, California) Lab Support, A Division Of On Assignment Senior Clinical Lab Scientist Assisting in setting up CLIA lab, including preparation of SOPs, writing validation protocols and reports, and performing validation testing. Performing complex laboratory analysis, instrument maintenance, quality control, and result reporting. • Bio NC (Durham, North Carolina) Allergan Inc. Principal Clinical Data Integration Programmer Will lead the acquisition, transformation, integration, specification, validation, implementation, and ongoing support of clinical research and development data from multiple sources using ETL technologies (e.g., Informatica Powercenter) and programs (e.g., SAS, PL/SQL) into target electronic systems (e.g., Clinical Data Repositories/Warehouses, Data Tabulation Datasets i.e., CDISC SDTM) used in Clinical Research and Development studies. • Genetown (Cambridge, Massachusetts) Sanofi Clinical Trials Operations Manager Responsible for the overall operational planning and activities for the implementation and conduct of studies (clinical trials, observational trials, compassionate use and registries) including data management activities in compliance with GCP's, SOPs and standards within established timelines and budgets. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Biotech Bay Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Health Discovery Corporation (DWCM.OB) Issues Update on Developments Relating to Intel RFE-SVM Patent More... •  DiaGenic ASA: Notice of Allowance of United States Family 3 Breast Cancer Patent More... •  Keck Graduate Institute Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients More... More Patent News •  iBio, Inc. (IBIO) Announces Production of Biosimilar Rituximab with Its iBioLaunch(TM) Technology More... More Drug Product News Hot Company OncoGenex Pharmaceuticals Inc. 1522 217th Place SE, Suite 100 Bothell, Washington 98021 U.S.A. Phone: 425-686-1500 Fax: 425-686-1600 OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. We have a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.